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Abstract
Currently, the efficacy of syphilis treatment is measured with anti-lipid antibody tests. These
can take months to indicate cure and, as a result, syphilis treatment trials require long peri-
ods of follow-up. The causative organism, Treponema pallidum (T. pallidum), is detectable
in the infectious lesions of early syphilis using DNA amplification. Bacteraemia can likewise
be identified, typically in more active disease. We hypothesise that bacterial clearance from
blood and ulcers will predict early the standard serology-measured treatment response and
have developed a qPCR assay that could monitor this clearance directly in patients with in-
fectious syphilis. Patients with early syphilis were given an intramuscular dose of ben-
zathine penicillin. To investigate the appropriate sampling timeframe samples of blood and
ulcer exudate were collected intensively for T. pallidum DNA (tpp047 gene) and RNA (16S
rRNA) quantification. Sampling ended when two consecutive PCRs were negative. Four
males were recruited. The mean peak level of T. pallidum DNA was 1626 copies/ml whole
blood and the mean clearance half-life was 5.7 hours (std. dev. 0.53). The mean peak of
16S rRNA was 8879 copies/ml whole blood with a clearance half-life of 3.9 hours (std. dev.
0.84). From an ulcer, pre-treatment, 67,400 T. pallidum DNA copies and 7.08x107 16S
rRNA copies were detected per absorbance strip and the clearance half-lives were 3.2 and
4.1 hours, respectively. Overall, T. pallidum nucleic acids were not detected in any sample
collected more than 56 hours (range 20–56) after treatment. All patients achieved serologic
cure. In patients with active early syphilis, measuring T. pallidum levels in blood and ulcer
exudate may be a useful measure of treatment success in therapeutic trials. These labora-
tory findings need confirmation on a larger scale and in patients receiving different
therapies.
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Author Summary
Syphilis is an infection that is spread both sexually and from mother-to-child. Worldwide,
it affects an estimated 11 million people each year. Treatment is available, but relies heavily
on penicillin and may not be as effective where the infection involves the brain or nervous
system. Clinical trials are needed to assess new treatments, but proving that people are
cured with current tests can take months. We developed a new test to measure the success
of treatment for the early stage of syphilis. We then used it in four patients and found that
the syphilis bacteria were cleared from the blood and ulcer samples collected by 56 hours.
All four patients were followed up with normal tests and found to have been cured. Our
new test is the first to show the speed of bacterial clearance after treatment and we plan to
use it in clinical trials of new treatments. Our data may also mean that patients with syphi-
lis are unable to pass on the infection three days after treatment, but this also needs prov-
ing on a larger scale.
Introduction
Syphilis is a multi-stage disease caused by the spirochete Treponema pallidum subspecies palli-
dum (T. pallidum) which is transmitted both sexually and from mother-to-child [1]. From the
late 1990s, the United Kingdom recorded large (ten-fold or more) increases in diagnosed cases
during epidemics characterised by male-to-male transmission and high rates of HIV-1 co-in-
fection (currently 64% in the UK) [1, 2]. Globally, the disease has remained prevalent with an
estimated incidence of 10.6 million cases each year [3]. This resurgence, and the need to reduce
mother-to-child transmission, has renewed interest in improved testing and treatment strate-
gies. The aim of the current study was to develop a novel way of safely investigating syphilis
treatments by directly measuring bacterial clearance following treatment.
The diagnosis of syphilis relies on serological tests; direct visualisation by dark ground mi-
croscopy (DGM) or PCR detection in infectious lesions [4]. Following direct contact with an
infected lesion, T. pallidum invades at the point of entry to produce the chancre of primary
syphilis and disseminates widely through the blood-stream and lymphatics, leading to the
multi-system secondary stage [5]. The infection is subject to significant but incomplete im-
mune clearance during the early stages and, if untreated, passes into an asymptomatic latent
phase [6]. Monitoring treatment can be achieved clinically, by observing the resolution of
symptoms and signs, and serologically by measuring a two-dilution (four-fold) fall in the titre
of anti-cardiolipin tests, namely the venereal disease research laboratory (VDRL) or rapid plas-
ma reagin (RPR) assays [7]. The requisite fall in RPR titre may not be observed for several
months as seen in a recent treatment study where a fifth of the (HIV-1 uninfected) patients
were termed ‘serofast’ at six months [8]. This creates uncertainty about the adequacy of treat-
ment, especially as only a small proportion (13%) of these patients responded (serologically) to
re-treatment with benzathine penicillin [9].
In recent years, PCR has increasingly replaced culture for the identification of pathogens.
Quantitative PCR (qPCR) is commonly used to quantify viruses, such as HIV-1 and Hepatitis
C in order to monitor treatment response. The quantification of bacteraemia by PCR not wide-
ly reported, but has been described for Streptococcus pneumoniae, Neisseria meningitidis, meth-
icillin-resistant Staphylococcus aureus (MRSA), and Acinetobacter baumannii [10–13]. It was
suggested for these infections that bacterial load is associated with disease severity and that the
rate of clearance may predict clinical outcome. A recent meta-analysis of 46 studies found the
sensitivity of T. pallidum PCR to be highest in primary genital or anal chancres (78.4%, 95% CI
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68.2%–86.0%). In blood, the highest sensitivities found were for congenital (83.0%, CI 55.0%–
95.2%) and secondary (52.2%, CI 37.3%–66.7%) disease [14]. For syphilis too, then, bacterae-
mia may be associated with disease activity. Quantitative measurement of T. pallidum in whole
blood established a range of 195 to 1954 polA gene copies/ml in one cross-sectional study of
secondary disease, and a mean of 516 tpp047 copies/ml whole blood in another [15, 16]. Until
now, serial measurements following treatment have not been made, thus a potential correlation
between bacterial clearance and serologic cure was unknown.
Using qPCR, we measured T. pallidum bacterial load in blood and ulcer exudate samples
from four patients with early syphilis both before and up to 150 hours after treatment with sin-
gle-dose parenteral penicillin. We compared the rate of bacterial clearance with clinical out-
come and standard serological follow-up.
Methods
Patients and samples
Patients with a microbiologically confirmed diagnosis of primary or secondary syphilis were
invited to participate. Primary disease was defined as a genital, or peri-anal chancre in which T.
pallidum was identified by DGM. Secondary disease was diagnosed in patients with consistent
symptoms and signs in the context of a positive enzyme immuno-assay (EIA) result and a RPR
titre of greater than one in eight.
Following informed consent, subjects were admitted to an in-patient facility and invited to
donate 4 ml whole blood, of which 3 ml were collected into a Tempus RNA preservation tube
(Life Technologies, UK), and 1 ml into EDTA. Each patient then received 2.4 megaunits of
benzathine penicillin by intramuscular injection. Subsequently, blood samples were drawn, as
above, two and six hours post-penicillin administration, then four-hourly for 48 hours (11
samples); six-hourly for 24 hours (four samples) and, finally, 12-hourly for up to four days
(maximum eight samples). Samples were placed on dry ice immediately following collection
and were processed in batches of up to eight. For the first patient, samples were collected at all
time-points. Subsequently, the duration of sample collection was informed by T. pallidum
clearance and ceased when two consecutive samples were negative by qPCR. Ulcer exudate was
collected with a filter paper Snostrip. First, the ulcer was abraded with sterile gauze and saline.
Next, exudate from the ulcer margin was absorbed up to the notch of the strip, the tip removed
with a sterile blade and placed into 1.3ml of RNAlater solution (Ambion, UK).
Following discharge, patients were invited to attend for RPR testing at one, three and six
months post-treatment. Serological cure was defined as a two-dilution (four-fold) reduction in
RPR titre.
Ethical approval for the study was obtained from the NRES Committee South East Coast
(Brighton and Sussex) (ref. 11/LO/0358). Informed, written consent was obtained from all
study participants.
Laboratory methods
Within 24 hours of collection, T. pallidum DNA was extracted from 500μl aliquots of whole
blood. Aliquots were added to 500μl of lysis buffer (20mM TrisHcl, pH 8.0; 0.2M EDTA; 1%
SDS) and incubated with 100μl of Proteinase K (Qiagen) for three hours at 65°C. Following ex-
traction with a proprietary extraction method (QiAmp, Qiagen, Crawley, UK), DNA was puri-
fied by ethanol precipitation and resuspended in 60μl of elution buffer (Qiagen). RNA was
extracted from blood in Tempus tubes according to the manufacturer’s protocol and resus-
pended in 100μl of the supplied elution solution. Positive and negative extraction controls were
included with each batch. DNA and RNA from Snostrip samples were extracted in a single
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procedure with an ‘all-prep mini kit’ (Qiagen). Snostrips in RNAlater were centrifuged at
14,000g and 4°C for 30 minutes and the upper 1.1ml of RNA later discarded. The remaining
200μl were added to 600μl or buffer RLT (Qiagen) which contained 0.143M beta-mercap-
toethanol. Following homogenization with a Qiashredder column (Qiagen) the resultant
DNA/RNA mixture was separated and extracted according to the manufacturer’s protocol.
RNA and DNA were eluted into 60μl and 100μl of RNAse-free water, respectively.
T. pallidum DNA quantification was achieved with qPCR using the CFX real-time system
(Biorad) to detect amplification of the tpp047 gene, which encodes a conserved 47 kDa outer
membrane protein. Each reaction contained 12.5μl 2x Quantitect PCR mix (Qiagen); 0.4μM of
the primers TP1 (5-CGAGGAATACAAGATTACGAACG-3) and TP2 (5-ACGTGCAGAAA
AACTATCCTCAG) and 0.2μM of the hydrolysis probe TP_P (FAM-CGGCCTCGCTCAGA
GATGAGC-TAMRA). Primer specificity had been assessed previously [15]. Cycling condi-
tions consisted of 15 minutes at 95°C then 44 cycles of 95°C for 15 seconds and 80 seconds at
60°C. Quantification was achieved using an ‘in-run’ plasmid standard of a 1:10 dilution series
from 105 to ten copies per reaction of the tpp047 target sequence. RNA quantification was per-
formed in a single-step RT-qPCR. Each 25μl reaction contained 1μl enzyme mix (reverse tran-
scriptase and taq polymerase) (Qiagen); 04mMDNTP mix; 5μl reaction buffer; 0.6μM of the
primers 16S_F (CTCTTTTGGACGTAGGTCTTTGAG) and 16S_R (TCACCCTCTCAG
GTCGGATA), and 0.2μM of the hydrolysis probe 16S_P3 (FAM-CGGCCTCGCTCAGAGA
TGAGC-TAMRA). Cycling conditions began with 50°C for 30 minutes, followed by 95°C for
15 minutes then 44 cycles of 95°C for 15 seconds and 60°C for 90 seconds. Absolute RNA
quantification was achieved with a 1:10 dilution series of T. pallidum 16S rRNA produced
using T7 polymerase on the recombinant plasmid containing the target sequence. For both
DNA and RNA quantification, samples were analysed in triplicate and two no-template
(water) controls were included in each experiment.
Results were analysed using SPSS v19. Statistical analysis is limited to descriptive statistics
and a two-tailed student’s t-test.
Results
Assay performance
The T. pallidum qPCR was found to have an analytical sensitivity of at least ten tpp047 copies/
reaction. The mean inter and intra-assay coefficients of variation (for the detection of 104
tpp047 copies/μl) were 2.35% (std. dev. 063) and 066% (std. dev. 017), respectively. The
quantification standard curve was 103% efficient with an average of 3.17 cycles between each
1:10 dilution. The RT-qPCR could detect a minimum of 23 16S rRNA copies/reaction with an
inter-assay variation coefficient (for the detection of 2.3x104 copies) of 3.05% (std. dev. 0.87)
and intra-assay variation of 0.34% (std. dev 0.09). The 16S rRNA absolute quantification stan-
dard curve was 87.7% efficient with an average of 3.66 cycles between each 1:10 dilution.
To compare the kinetics of T. pallidum DNA and rRNA clearance, two parameters were cal-
culated. The first, time to clearance, was the time elapsed between administration of treatment
and the point half way between the first of the consecutively negative time-point and the last
detectable time-point. The second, clearance half-life, was based on the exponential decay
equation:
NðtÞ ¼ N0
1
2
 t=t12
N(t) is the quantity remaining after a time t; N0 is the initial quantity, and t
1/2 is the half-life of
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the decaying quantity. By measuring the coefﬁcient of variation (R2) for an exponential regres-
sion line, the rate of nucleic acid clearance in both ulcer and blood samples was found to be ex-
ponential, thus half-life was an appropriate measure of clearance.
T. pallidum quantification
Three of four patients recruited were found to have detectable T. pallidum bacteraemia pre-treat-
ment and it was possible to document changes in the bacterial load over time. The fourth patient
recruited was bacteraemic at time points four, six, eight and nine (between six and 30 hours
post-treatment), but initially negative and was excluded from analyses. Baseline characteristics
for all patients are presented in Table 1.
Samples from patients STS1, STS2, and STS3 showed similar patterns of T. pallidum nucleic
acid clearance from blood following treatment (Table 2 and Fig. 1). The mean peak tpp047 level,
which occurred two to ten hours post-treatment, was 1626 copies/ml whole blood (std. dev. 652).
Peak 16S rRNA levels (8879 copies/ml whole blood, std. dev. 11109) were detected at similar
time-points. While the peak of tpp047DNA was similar for all three patients, that of 16S rRNA
for patient STS3 was ten-fold higher than for STS1 and STS2. Following peak bacteraemia, both
RNA and DNA levels fell quickly, with neither detectable in any patient after 56 hours. The mean
time to tpp047DNA clearance was 34 hours (std. dev. 8) and 29 hours (std. dev. 23.86) for 16S
rRNA. The 16S rRNA time to clearance measured for patient STS3 was 56 hours, as a result of
low-level (35 copies/ml) 16S rRNA detection at 56 hours following two negative samples at 42
and 46 hours. This 16S rRNA amplification at 56 hours was observed in two of three technical
replicates during two separate experiments. Furthermore, both the negative Tempus™ extraction
control and the two no-template PCR negative controls were negative. The mean half-life of
T. pallidum tpp047DNA clearance from blood was determined to be 5.68 hours (std. dev 0.53)
and was significantly longer than the 3.89 hours (std. dev. 0.84) calculated for 16S rRNA
(p = 0.035, two-tailed t-test).
In order to exclude the possibility of a late recrudescence in bacterial load, blood from pa-
tient STS1 was sampled for both DNA and RNA quantification until 150 hours post-treatment.
Neither was detectable following initial clearance at 32 (RNA) and 40 (DNA) hours.
Patient STS3 presented with a DGM positive genital ulcer and samples were collected con-
currently with each blood sample. Table 2 and Fig. 2 demonstrate an initial ulcer tpp047 load of
34,000 DNA copies/strip, which peaked (67,400 DNA copies/strip) at 14 hours and remained
high until 26 hours, thereafter decreasing rapidly. At 50 hours following treatment, tpp047
DNA was no longer detectable. The decay of tpp047 DNA fitted an exponential regression line
Table 1. Patient information: Baseline characteristics and serology.
Patient Demographics HIV-1 Stage/Signs Baseline serology
STS1 Age 48 years; Male; White
British; homosexual
HIV-1 infected ; CD4 640 cells/mm3 ; treated with
Lopinavir/Ritonavir/Tenofovir; viral load <50 copies/
ml
Secondary stage with rash affecting
trunk and palms. No CNS
involvement
EIA positive; TPPA
positive; RPR 1:64
STS 2 Age 45 years; Male; White
Brazilian; homosexual
HIV-1 infected ; CD4 776 cells/mm3 ; treated with
Efavirenz/Tenofovir/ Emtricitabine; Viral load <50
copies/ml
Secondary stage with rash affecting
trunk, arms and legs. No CNS
involvement
EIA positive; TPPA
positive; RPR 1:32
STS 3 Age 26 years; Male; Black
British; Homosexual
Negative Primary stage with painless penile
chancre of four weeks’ duration
EIA positive; TPPA
positive; RPR 1:32
STS 4 Age 35 years; Male; White
Brazilian; Homosexual
HIV-1 infected ; CD4 820 cells/mm3 ; treated with
Darunavir/Ritonavir/ Tenofovir/Emtricitabine; Viral
load <50 copies/ml
Secondary stage with a feint rash,
intermittent headache, healed
penile ulcer
EIA positive; TPPA
positive; RPR 1:64
doi:10.1371/journal.pntd.0003492.t001
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(R2 = 0.878) and the clearance half-life was 3.2 hours. The quantity of 16S rRNA followed a
similar pattern, although this peaked earlier, at two hours post-treatment, and higher, at a level
1000 times greater than for DNA (7.08x107 copies/strip). After 40 hours, the level fell exponen-
tially (R2 = 0.839) to become undetectable by 56 hours. Clearance half-life was 4.1 hours.
The clearance of both DNA and 16S rRNA was measured both to improve T. pallidum de-
tection (the 16S ribosomal RNA target was predicted to be present at 5000–10000 copies per
organism) and to compare clearance, predicted to be shorter for RNA which is inherently less
stable [17]. The half-life of T. pallidum DNA clearance was found to be significantly longer
than 16S rRNA (5.7 hours versus 3.9 hours, p = 0035).
Patient progress and follow-up
Patients STS1, STS2 and STS3 all developed an inflammatory Jarisch-Herxheimer reaction
(JHR) eight to 12 hours after penicillin administration. This included a worsening of rash for
patients STS1 and STS2 over a one-to-two day period. At one month, clinical signs and symp-
toms had resolved in all three patients and serological results were consistent with cure
(Table 3). This serological response was maintained at three and six months.
Discussion
We present the development of a qPCR assay for quantifying T. pallidum in clinical samples
and some early observations from a small, uncontrolled clinical study of patients with early
Table 2. Measurement of T. pallidum clearance post-treatment.
Patient STS1 STS2 STS3 Mean Std. dev.
Blood DNA
t1/2 (hours) 5.79 6.15 5.11 5.68* 0.53
Peak bacteraemia (tpp047 copies/ml) 2151 895 1832 1626 653
Peak Bacteraemia (hours) 2 0 2 1.33 1.15
Time to clearance (hours) 40 24 32 32.00 8.00
Blood RNA
t1/2 (hours) 3.87 3.07 4.75 3.89* 0.84
Peak bacteraemia (16S rRNA copies/ml) 3635 1363 21640 8879.33 11109.30
Peak bacteraemia (hours) 2 10 6 6.00 4.00
Time to clearance (hours) 32 20 53 35.00 16.70
Ulcer DNA
t1/2 (hours) x x 3.19 x x
Peak ulcer load (tpp047 copies/strip) x x 67400 x x
Time of peak load (hours) x x 14 x x
Time to clearance (hours) x x 50 x x
Ulcer RNA
t1/2 (hours) x x 4.08 x x
Peak ulcer load (16S rRNA copies/strip) x x 7.08e7 x x
Time of peak load (hours) x x 2 x x
Time to clearance (hours) x x 56** x x
* p = 0.035 (2-sided t-test of t1/2(RNA clearance) vs t1/2(DNA clearance)
** The last sample collected was the ﬁrst negative sample.
doi:10.1371/journal.pntd.0003492.t002
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syphilis treated with Benzathine penicillin, which highlights the potential clinical application of
the assay.
Confirming adequate treatment for syphilis with serological tests can be slow (up to
12 months) and problematic due to the non-specific nature of serum RPR testing [7, 8]. Using
serial sampling and novel qPCR assays, we have demonstrated clearance of T. pallidum nucleic
Fig 1. Three patients with microbiologically confirmed early syphilis were treated with a 2.4 megaunit dose of benzathine penicillin at time zero.
Panels A to C represent DNA clearance for three patients and Panels D to F depict RNA clearance for the same patients. Error bars represent 95%
confidence intervals.
doi:10.1371/journal.pntd.0003492.g001
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acids from blood and ulcer exudate within 56 hours of treatment with benzathine penicillin in
four patients. We have also described the kinetics of this response and found the half-life for
blood clearance of T. pallidum to be 5.7 hours for DNA and 3.9 hours for RNA. For an ulcer,
bacterial DNA and RNA clearance half-lives were 3.2 and 4.1 hours, respectively. All patients
were cured by their treatment, showing both a clinical and serologic response.
Syphilis disease activity varies through the course of the infection giving rise to early (symp-
tomatic) and late (asymptomatic) clinical stages. The secondary stage, characterised by system-
ic disease (rash, hepatitis, neurologic involvement) is arguably the most active and is the stage
during which patients are most likely to be bacteraemic [14, 18]. Blood bacterial load has been
measured by qPCR in a number of infections and correlated with disease activity. In patients
with meningococcal disease, the level of bacteraemia at admission was significantly higher in
individuals with severe disease and in those who died [11] and in MRSA bacteraemia where
mecA DNA levels were significantly higher in non-survivors compared with survivors [12].
When the bacterial load of Acinetobacter baumannii in critical care patients was followed lon-
gitudinally, a slower rate of clearance was associated with increased mortality. Moreover, the
use of appropriate antibiotics resulted in quicker bacterial clearance [13]. The sensitivity of
Fig 2. A patient presenting with a DGM positive penile ulcer (primary syphilis) was administered a 2.4 megaunit dose of benzathine penicillin at
time zero.Ulcer samples for T. pallidum DNA and RNA quantification were collected pre-treatment and then four hourly for 56 hours. Panel A. presents DNA
(tpp047) decay and Panel B. shows 16S rRNA decay.
doi:10.1371/journal.pntd.0003492.g002
Table 3. Serological follow-up of patients
Rapid Plasma Reagin titre
Baseline One month Three months Six months
Case 1 1:64 1:4 negative negative
Case 2 1:32 1:4 1:1 1:4
Case 3 1:32 1:2 * negative
Case 4 1:64 unavailable 1:4 1:2
* Result is missing as the patient did not attend for phlebotomy
doi:10.1371/journal.pntd.0003492.t003
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T. pallidum PCR in blood is too low for it to be a reliable diagnostic test, especially in primary
and latent disease. However, our data suggest that in selected patients with active early disease
it may prove a useful marker of disease activity. Moreover, in the context of a clinical study of
early syphilis treatment, qPCR may also conceivably be used to monitor bacterial clearance
and quickly identify potential treatment failure.
The primary chancre of syphilis develops at the site of initial infection following bacterial di-
vision and invasion and, as such, has a high bacterial load. PCR detection of T. pallidum in
these lesions is now established as a diagnostic tool for the disease. The chancre is also the most
likely source of bacteria for onward transmission of the disease, thus the period of infectious-
ness following treatment is of interest. In the current study DNA and RNA from an ulcer were
undetectable 50 and 56 hours following treatment, respectively. If proven in a larger clinical
study, this may be of use for counseling patients regarding abstinence following syphilis
treatment.
To our knowledge, there is no previous description of T. pallidum qPCR detection in animal
or human samples to measure treatment response following therapy. The intensity of monitor-
ing in this study enabled the observed rapid bacterial clearance to be measured accurately and
serologic follow-up of patients was robust enabling a potential association between bacterial
clearance and serologic cure to be identified. At present, our demonstration of bacterial clear-
ance is limited to the study of four patients and requires confirmation on a much larger scale to
become clinically useable. Moreover, whilst the clearance of bacterial DNA was measured, it is
unknown whether the DNA detected was from living or dead organisms. As T. pallidum is
non-culturable, Rabbit Infectivity Testing (RIT), where test animals are injected with clinical
material in order to propagate and identify T. pallidum, could have been used to assess persis-
tence following treatment [19, 20]. This approach would, however, have required the sacrifice
of a large number of animals. A final limitation is that all four patients in the current study re-
ceived benzathine penicillin treatment. Whilst this was deliberate, in order to define the precise
moment of treatment, we acknowledge that bacterial clearance time following treatment with
oral antibiotics may be different.
In recent clinical trials of syphilis treatments, enrolled patients waited for a minimum of six
months following the administration of the trial drug before cure (defined as a four-fold reduc-
tion in RPR titre) was diagnosed [21, 22]. The investigation of new syphilis treatments is much
needed, but to leave patients potentially untreated for six months while waiting for a serologic
response is far from ideal. We hypothesise that for patients with early stage syphilis, which is
PCR-positive at baseline, a clearance half-life of less than six hours or absence of bacterial nu-
cleic acids at three days indicates bacterial clearance and is potentially a new measure of treat-
ment success. In order to prove this, a larger observational study of syphilis treatment response
is required. This proposed study would require both HIV-1 uninfected and uninfected patients
with untreated primary, secondary and early latent syphilis. We propose that five sample time-
points based on these preliminary data (pre-treatment, 12, 24, 56 and 72 hours post-treatment)
should be used to compare bacterial clearance following treatment with both parenteral peni-
cillin and oral antibiotics, such as doxycycline. Bacterial clearance would be correlated with se-
rologic and clinical cure.
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